Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome

Monica Gomaraschi, Alice Ossoli, Elda Favari, Maria Pia Adorni, Gianfranco Sinagra, Luigi Cattin, Fabrizio Veglia, Franco Bernini, Guido Franceschini, Laura Calabresi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Aims: The aim of the present study was to evaluate the high-density lipoprotein (HDL) structure and endothelial NO synthase (eNOS) activation capacity in ST-elevation myocardial infarction (STEMI) patients with different acute-phase inflammatory response (APR). Methods and results: Forty-five STEMI patients were stratified in quartiles according to the delta CRP level, calculated by subtracting the CRP value atadmission from the CRP peak value (APR peak). The HDL structure and HDL capacity tostimulate NO production were evaluated at admission and at APRpeak. STEMI patients with a low APR had a completely preserved HDL structure and HDL ability to activate eNOS and promote NO production, which did not change during STEMI. On the contrary, HDL from STEMI patients developing a significant APR had compromised ability to stimulate eNOS and promote NO production, and underwent a significant particle remodelling during STEMI. The defective capacity to stimu-late NO production of HDL isolated from STEMI patients with high APR was explained, at least in part, by the reduced PON-1 and S1P content. The HDL ability to promote cell cholesterol efflux through different pathways was preserved in ACS patients independently of the inflammatory response. Conclusion: The present results extend previous studies reporting an impaired eNOS-activating capacity of HDL from ACS patients, showing that only a subset of patients undergoing STEMI, and in particular those developing an important inflammatory response, have circulating HDL defective in stimulating endothelial eNOS and NO production.

Original languageEnglish
Pages (from-to)36-43
Number of pages8
JournalCardiovascular Research
Volume100
Issue number1
DOIs
Publication statusPublished - Oct 1 2013

Fingerprint

HDL Lipoproteins
Acute Coronary Syndrome
Nitric Oxide Synthase
Inflammation
Acute-Phase Reaction
ST Elevation Myocardial Infarction
Cholesterol

Keywords

  • Acute inflammatory response
  • Acute myocardial infarction
  • High-density lipoproteins
  • Nitric oxide

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Physiology

Cite this

Gomaraschi, M., Ossoli, A., Favari, E., Adorni, M. P., Sinagra, G., Cattin, L., ... Calabresi, L. (2013). Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome. Cardiovascular Research, 100(1), 36-43. https://doi.org/10.1093/cvr/cvt169

Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome. / Gomaraschi, Monica; Ossoli, Alice; Favari, Elda; Adorni, Maria Pia; Sinagra, Gianfranco; Cattin, Luigi; Veglia, Fabrizio; Bernini, Franco; Franceschini, Guido; Calabresi, Laura.

In: Cardiovascular Research, Vol. 100, No. 1, 01.10.2013, p. 36-43.

Research output: Contribution to journalArticle

Gomaraschi, M, Ossoli, A, Favari, E, Adorni, MP, Sinagra, G, Cattin, L, Veglia, F, Bernini, F, Franceschini, G & Calabresi, L 2013, 'Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome', Cardiovascular Research, vol. 100, no. 1, pp. 36-43. https://doi.org/10.1093/cvr/cvt169
Gomaraschi M, Ossoli A, Favari E, Adorni MP, Sinagra G, Cattin L et al. Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome. Cardiovascular Research. 2013 Oct 1;100(1):36-43. https://doi.org/10.1093/cvr/cvt169
Gomaraschi, Monica ; Ossoli, Alice ; Favari, Elda ; Adorni, Maria Pia ; Sinagra, Gianfranco ; Cattin, Luigi ; Veglia, Fabrizio ; Bernini, Franco ; Franceschini, Guido ; Calabresi, Laura. / Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome. In: Cardiovascular Research. 2013 ; Vol. 100, No. 1. pp. 36-43.
@article{607165c380714caca233814f7c4eef07,
title = "Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome",
abstract = "Aims: The aim of the present study was to evaluate the high-density lipoprotein (HDL) structure and endothelial NO synthase (eNOS) activation capacity in ST-elevation myocardial infarction (STEMI) patients with different acute-phase inflammatory response (APR). Methods and results: Forty-five STEMI patients were stratified in quartiles according to the delta CRP level, calculated by subtracting the CRP value atadmission from the CRP peak value (APR peak). The HDL structure and HDL capacity tostimulate NO production were evaluated at admission and at APRpeak. STEMI patients with a low APR had a completely preserved HDL structure and HDL ability to activate eNOS and promote NO production, which did not change during STEMI. On the contrary, HDL from STEMI patients developing a significant APR had compromised ability to stimulate eNOS and promote NO production, and underwent a significant particle remodelling during STEMI. The defective capacity to stimu-late NO production of HDL isolated from STEMI patients with high APR was explained, at least in part, by the reduced PON-1 and S1P content. The HDL ability to promote cell cholesterol efflux through different pathways was preserved in ACS patients independently of the inflammatory response. Conclusion: The present results extend previous studies reporting an impaired eNOS-activating capacity of HDL from ACS patients, showing that only a subset of patients undergoing STEMI, and in particular those developing an important inflammatory response, have circulating HDL defective in stimulating endothelial eNOS and NO production.",
keywords = "Acute inflammatory response, Acute myocardial infarction, High-density lipoproteins, Nitric oxide",
author = "Monica Gomaraschi and Alice Ossoli and Elda Favari and Adorni, {Maria Pia} and Gianfranco Sinagra and Luigi Cattin and Fabrizio Veglia and Franco Bernini and Guido Franceschini and Laura Calabresi",
year = "2013",
month = "10",
day = "1",
doi = "10.1093/cvr/cvt169",
language = "English",
volume = "100",
pages = "36--43",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Inflammation impairs eNOS activation by HDL in patients with acute coronary syndrome

AU - Gomaraschi, Monica

AU - Ossoli, Alice

AU - Favari, Elda

AU - Adorni, Maria Pia

AU - Sinagra, Gianfranco

AU - Cattin, Luigi

AU - Veglia, Fabrizio

AU - Bernini, Franco

AU - Franceschini, Guido

AU - Calabresi, Laura

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Aims: The aim of the present study was to evaluate the high-density lipoprotein (HDL) structure and endothelial NO synthase (eNOS) activation capacity in ST-elevation myocardial infarction (STEMI) patients with different acute-phase inflammatory response (APR). Methods and results: Forty-five STEMI patients were stratified in quartiles according to the delta CRP level, calculated by subtracting the CRP value atadmission from the CRP peak value (APR peak). The HDL structure and HDL capacity tostimulate NO production were evaluated at admission and at APRpeak. STEMI patients with a low APR had a completely preserved HDL structure and HDL ability to activate eNOS and promote NO production, which did not change during STEMI. On the contrary, HDL from STEMI patients developing a significant APR had compromised ability to stimulate eNOS and promote NO production, and underwent a significant particle remodelling during STEMI. The defective capacity to stimu-late NO production of HDL isolated from STEMI patients with high APR was explained, at least in part, by the reduced PON-1 and S1P content. The HDL ability to promote cell cholesterol efflux through different pathways was preserved in ACS patients independently of the inflammatory response. Conclusion: The present results extend previous studies reporting an impaired eNOS-activating capacity of HDL from ACS patients, showing that only a subset of patients undergoing STEMI, and in particular those developing an important inflammatory response, have circulating HDL defective in stimulating endothelial eNOS and NO production.

AB - Aims: The aim of the present study was to evaluate the high-density lipoprotein (HDL) structure and endothelial NO synthase (eNOS) activation capacity in ST-elevation myocardial infarction (STEMI) patients with different acute-phase inflammatory response (APR). Methods and results: Forty-five STEMI patients were stratified in quartiles according to the delta CRP level, calculated by subtracting the CRP value atadmission from the CRP peak value (APR peak). The HDL structure and HDL capacity tostimulate NO production were evaluated at admission and at APRpeak. STEMI patients with a low APR had a completely preserved HDL structure and HDL ability to activate eNOS and promote NO production, which did not change during STEMI. On the contrary, HDL from STEMI patients developing a significant APR had compromised ability to stimulate eNOS and promote NO production, and underwent a significant particle remodelling during STEMI. The defective capacity to stimu-late NO production of HDL isolated from STEMI patients with high APR was explained, at least in part, by the reduced PON-1 and S1P content. The HDL ability to promote cell cholesterol efflux through different pathways was preserved in ACS patients independently of the inflammatory response. Conclusion: The present results extend previous studies reporting an impaired eNOS-activating capacity of HDL from ACS patients, showing that only a subset of patients undergoing STEMI, and in particular those developing an important inflammatory response, have circulating HDL defective in stimulating endothelial eNOS and NO production.

KW - Acute inflammatory response

KW - Acute myocardial infarction

KW - High-density lipoproteins

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=84887947938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887947938&partnerID=8YFLogxK

U2 - 10.1093/cvr/cvt169

DO - 10.1093/cvr/cvt169

M3 - Article

VL - 100

SP - 36

EP - 43

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 1

ER -